Antihypertensive Medications: Benefits, Risks & Collaborative Management

Benefits (Evidence-Based)

  • BP Reduction: Lowers SBP/DBP, reducing cardiac afterload.
  • CV Event Prevention: ↓ Stroke (~35–40%), ↓ MI (~20–25%), ↓ Heart Failure (~50%).
  • Renal Protection: Slows CKD progression (especially ACEi/ARB).
  • Retinal Protection: Reduces hypertensive retinopathy.
  • Cognitive Protection: Midlife BP control lowers dementia risk.

Common Drug Classes & Key Side Effects

Management Principles

  • Start Low, Go Slow: Titrate to target (usually <130/80).
  • Combination Therapy: Often needed; use complementary mechanisms (e.g., ACEi + CCB + thiazide). Single-pill combos improve adherence.
  • Monitor: BP (home + office), electrolytes, Cr, eGFR, K⁺, glucose, uric acid.
  • Lifestyle Synergy: DASH diet, Na⁺ <2.3g, exercise, weight loss, limit alcohol, quit smoking.
  • Address Side Effects Proactively: Switch class if intolerable; don't just stop.
  • Adherence: Simplify regimen, use pillboxes, apps, 90-day fills.

Special Populations

  • Pregnancy: Methyldopa, labetalol, nifedipine preferred; avoid ACEi/ARB/diuretics.
  • Black Patients: Better response to CCB/thiazide; ACEi/ARB less effective as monotherapy.
  • Elderly: Orthostatic hypotension risk; start lower, monitor standing BP.

Hypertension - Related Articles

Health Sciences © https://www.222health.com

ClassExamplesNotable Adverse Effects
ACE InhibitorsLisinopril, RamiprilDry cough (10–20%), angioedema (rare), hyperkalemia, ↑ Cr (bilateral RAS)
ARBsLosartan, ValsartanSimilar to ACEi but no cough; hyperkalemia, ↑ Cr.
Thiazide/Thiazide-like DiureticsChlorthalidone, IndapamideHypokalemia, hyponatremia, hyperglycemia, hyperuricemia, ↑ LDL.
Loop DiureticsFurosemideElectrolyte depletion, ototoxicity (high dose IV), volume depletion.
Calcium Channel BlockersAmlodipine (DHP), Diltiazem/Verapamil (non-DHP)DHP: edema, flushing, headache. Non-DHP: bradycardia, constipation.
Beta-BlockersMetoprolol, Carvedilol, BisoprololFatigue, bradycardia, bronchospasm (non-selective), ED, depression, masking hypoglycemia.
Mineralocorticoid Receptor AntagonistsSpironolactone, EplerenoneHyperkalemia, gynecomastia (spiro), renal dysfunction.
Central Alpha-2 AgonistsClonidineSedation, dry mouth, rebound HTN if stopped abruptly.